Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloprotease inhibitors: design from structure.

N Borkakoti1

  • 1Chemical Technologies, Roche Products Ltd, Broadwater Road, Welwyn Garden City, Herts. AL7 3AY, UK. Neera.Borkakoti@medivir.com

Biochemical Society Transactions
|January 30, 2004
PubMed
Summary

Matrix metalloproteases (MMPs) degrade extracellular matrix, and their inhibitors are key therapeutic targets for diseases like cancer and arthritis. Research focuses on designing specific MMP inhibitors to restore tissue balance and improve clinical efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The structural basis of matrix metalloproteinase inhibition.

Current opinion in drug discovery & development·2009
Same author

From structure to function: approaches and limitations.

Nature structural biology·2000
Same author

Structural studies of matrix metalloproteinases.

Journal of molecular medicine (Berlin, Germany)·2000
Same author

Matrix metalloproteases: variations on a theme.

Progress in biophysics and molecular biology·1998
Same author

TESS: a geometric hashing algorithm for deriving 3D coordinate templates for searching structural databases. Application to enzyme active sites.

Protein science : a publication of the Protein Society·1998
Same author

Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements.

Journal of virology·1997

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Matrix metalloproteases (MMPs) are zinc- and calcium-dependent enzymes crucial for extracellular matrix degradation.
  • An imbalance between active MMPs and endogenous inhibitors contributes to connective tissue destruction in diseases like arthritis, cancer, and cardiovascular conditions.

Purpose of the Study:

  • To critically appraise the design principles of matrix metalloprotease inhibitors (MMPIs).
  • To explore challenges and strategies for achieving clinical efficacy with MMPI-based therapies.

Main Methods:

  • Review of existing literature on MMP inhibitor design and development.
  • Analysis of structural and sequence data to understand MMP active sites and specificity pockets.
  • Examination of therapeutic strategies involving MMPIs.

Related Experiment Videos

Main Results:

  • Early MMPI design focused on mimicking substrate scissile sites and chelating the active site zinc ion.
  • X-ray and NMR data enabled the development of subtype-selective MMPIs by exploiting enzyme specificity pockets.
  • Intensive research is ongoing to develop low-molecular-mass inhibitors for therapeutic applications.

Conclusions:

  • Effective MMPI design requires understanding enzyme structure-activity relationships and specificity.
  • Overcoming challenges in clinical efficacy is crucial for MMPI-based therapies.
  • Targeting MMPs offers a promising therapeutic avenue for various diseases.